Dr. Anna Mackin, MD

Dr. Mackin practices at Vistar Eye Center, Inc in Roanoke, Virginia.

Dr. Mackin's NPI, 1245619105, was assigned on May 26, 2015. Dr. Mackin graduated from University of Colorado School of Medicine, Aurora in 2015. Dr. Mackin holds Virginia license 0101271654.

Dr. Mackin's primary practice is Vistar Eye Center, Inc, at 6125 Airport Rd, Roanoke, VA 24019 in Roanoke County. The practice phone is (540) 855-5139.

Dr. Mackin's primary practice is Vistar Eye Center, Inc in Roanoke, Virginia. Dmand AI also links Dr. Mackin to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mackin practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Mackin's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dmand AI has Dr. Mackin's licenses on file in 3 states: Virginia, Colorado and Illinois.

CMS data shows 75,938 Medicare services from Dr. Mackin across 19 procedure codes in 2024, for 1,051 Medicare patients. Medicare paid $3,010,072 for them. Every service was in an office.

CMS counts 1,051 Medicare patients who saw Dr. Mackin in 2024. The largest group is 75 to 84, with 419 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mackin's median patient age at 73, with 54% women.

In 2024, Dr. Mackin wrote 865 Medicare Part D claims for 288 patients. 69% of them were for generic drugs. CMS names the drug for 797 of them, across 14 drugs with 11 or more claims each, at $18,435 in total drug cost. In 2023, CMS named 719 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mackin for performance year 2024, reported as part of a group. Dr. Mackin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Mackin, published from 2020 to 2022. 2020 was the busiest year, with 3. The most frequent topics are Vitrectomy, Retinal Detachment and Tomography, Optical Coherence. Dr. Mackin has published most often in Retin Cases Brief Rep. Dr. Mackin's most frequent co-authors are David Thanh Duc Dao, MD, Dimitra Skondra, MD and Lincoln Shaw.

CMS Open Payments shows 196 general payments to Dr. Mackin from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Abbvie Inc. paid the most, $7,207. It also lists 1 research payment totaling $10,534 in 2025.

Dr. Mackin graduated from University of Colorado School of Medicine, Aurora in 2015.